These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20186175)

  • 1. The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period.
    Takahashi S; Okada K; Yanai M
    Kidney Int Suppl; 2010 Mar; (116):S17-23. PubMed ID: 20186175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.
    Obrador GT; García-García G; Villa AR; Rubilar X; Olvera N; Ferreira E; Virgen M; Gutiérrez-Padilla JA; Plascencia-Alonso M; Mendoza-García M; Plascencia-Pérez S
    Kidney Int Suppl; 2010 Mar; (116):S2-8. PubMed ID: 20186176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.
    Obrador GT; Villa AR; Olvera N; Gutiérrez V; Contreras D; Reyes R
    Arch Med Res; 2013 Nov; 44(8):650-4. PubMed ID: 24211753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R; Li S; Wang C; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kidney Early Evaluation Program (KEEP) of Japan.
    Nitta K; Okada K; Yanai M; Takahashi S
    Clin Nephrol; 2015; 83(7 Suppl 1):52-5. PubMed ID: 25725243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for chronic kidney disease in Australia: a pilot study in the community and workplace.
    Mathew TH; Corso O; Ludlow M; Boyle A; Cass A; Chadban SJ; Joyner B; Shephard M; Usherwood T
    Kidney Int Suppl; 2010 Mar; (116):S9-16. PubMed ID: 20186177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2010 Dec; 14(6):558-70. PubMed ID: 20700621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    McCullough PA; Li S; Jurkovitz CT; Stevens LA; Wang C; Collins AJ; Chen SC; Norris KC; McFarlane SI; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti JA; Whaley-Connell AT;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S38-45. PubMed ID: 18359407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease and risk factor prevalence in Saint Kitts and Nevis: a cross-sectional study.
    Crews DC; Campbell KN; Liu Y; Bussue O; Dawkins I; Young BA
    BMC Nephrol; 2017 Jan; 18(1):7. PubMed ID: 28056873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; McFarlane SI; Norris KC; Chen SC; Li S; Qiu Y; Wang C; Stevens LA; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S21-9. PubMed ID: 18359404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study.
    Alkerwi A; Sauvageot N; El Bahi I; Delagardelle C; Beissel J; Noppe S; Roderick PJ; Mindell JS; Stranges S
    BMC Nephrol; 2017 Dec; 18(1):358. PubMed ID: 29221436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The See Kidney Disease Targeted Screening Program for CKD.
    Galbraith LE; Ronksley PE; Barnieh LJ; Kappel J; Manns BJ; Samuel SM; Jun M; Weaver R; Valk N; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):964-972. PubMed ID: 27197905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of and factors contributing to chronic kidney disease in a middle-aged working population.
    Noborisaka Y; Ishizaki M; Yamada Y; Honda R; Yokoyama H; Miyao M; Tabata M
    Environ Health Prev Med; 2013 Nov; 18(6):466-76. PubMed ID: 23728725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic kidney disease in an adult population.
    Cueto-Manzano AM; Cortés-Sanabria L; Martínez-Ramírez HR; Rojas-Campos E; Gómez-Navarro B; Castillero-Manzano M
    Arch Med Res; 2014 Aug; 45(6):507-13. PubMed ID: 24992221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey.
    De Nicola L; Donfrancesco C; Minutolo R; Lo Noce C; Palmieri L; De Curtis A; Iacoviello L; Zoccali C; Gesualdo L; Conte G; Vanuzzo D; Giampaoli S;
    Nephrol Dial Transplant; 2015 May; 30(5):806-14. PubMed ID: 25523453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.